St. Jude launches Infinity deep brain stim system in the EU

St. Jude Medical (NYSE:STJ) today announced the European launch of its Infinity deep brain stimulation system and direction DBS lead, designed to support treatments for movement disorders. The Infinity DBS system won CE Mark approval in the European Union last September. “The Infinity system is the 1st DBS system I’ve encountered that adjusts to the patient’s individual needs, rather than forcing the patient to adjust to the system. Offering my patients a DBS system with exceptional ease of use and smooth manageability is an exciting step in the treatment of debilitating movement disorders,” Jan Vesper of Düsseldorf, Germany’s University Hospital, the 1st practicing physician to implant the system, said in a press release. St. Jude said the Infinity system is designed so that Apple (NSDQ:AAPL) mobile devices can be used as wireless controllers, via a Bluetooth connection, and that it’s the only upgradable DBS system for movement disorders including Parkinson’s disease, tremor and dystonia. The directional leads are designed to allow doctors to “steer” current to different parts of the brain, tailoring treatment to reduce side effects, St. Jude said. “The Infinity DBS system and directional lead design was designed to meet the needs of physicians who confirmed that they needed a system that prioritized improved stimulation targeting, device longevity and improved patient ease of use. The Infinity DBS system is our answer fo...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Neurological St. Jude Medical Source Type: news